Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case-control study.

Guevara M, Barricarte A, Torroba L, Herranz M, Gil-Setas A, Gil F, Bernaola E, Ezpeleta C, Castilla J; Working Group for Surveillance of the Pneumococcal Invasive Disease in Navarra.

Euro Surveill. 2016;21(14). doi: 10.2807/1560-7917.ES.2016.21.14.30186.

2.

Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps.

Fernández-Cuenca F, Tomás M, Caballero-Moyano FJ, Bou G, Martínez-Martínez L, Vila J, Pachón J, Cisneros JM, Rodríguez-Baño J, Pascual Á; Spanish Group of Nosocomial Infections (GEIH) from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI); Spanish Group of Nosocomial Infections GEIH from the Spanish Society of Clinical Microbiology and Infectious Diseases SEIMC and the Spanish Network for Research in Infectious Diseases REIPI.

J Antimicrob Chemother. 2015 Dec;70(12):3222-9. doi: 10.1093/jac/dkv262. Epub 2015 Sep 10.

PMID:
26517560
3.

Cause of death in hospitalized patients with laboratory-confirmed influenza.

Casado I, Martínez-Baz I, Floristán Y, Chamorro J, Ezpeleta C, Castilla J; Network for Influenza Surveillance in Hospitals of Navarra.

An Sist Sanit Navar. 2015 May-Aug;38(2):263-8.

4.

Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.

Martínez-Baz I, Navascués A, Pozo F, Chamorro J, Albeniz E, Casado I, Reina G, Cenoz MG, Ezpeleta C, Castilla J; Primary Health Care Sentinel Network and Network for Influenza Surveillance in Hospitals of Navarra.

Hum Vaccin Immunother. 2015;11(7):1626-33. doi: 10.1080/21645515.2015.1038002.

5.

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.

Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, Galtier F, Hak E, Guevara M, Costanzo S; European hospital IVE network, Moren A.

Euro Surveill. 2015 Jan 15;20(2). pii: 21011. Erratum in: Euro Surveill. 2015;20(3). pii: 21015. Niesters, Hubert [added].

6.

Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort.

López-Cortés LE, Cisneros JM, Fernández-Cuenca F, Bou G, Tomás M, Garnacho-Montero J, Pascual A, Martínez-Martínez L, Vila J, Pachón J, Rodríguez Baño J; GEIH/REIPI-Ab2010 Group.

J Antimicrob Chemother. 2014 Nov;69(11):3119-26. doi: 10.1093/jac/dku233. Epub 2014 Jun 25.

PMID:
24970742
7.

Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system.

Mosqueda N, Gato E, Roca I, López M, de Alegría CR, Fernández Cuenca F, Martínez-Martínez L, Pachón J, Cisneros JM, Rodríguez-Baño J, Pascual A, Vila J, Bou G, Tomás M; GEIH-GEMARA (SEIMC) and REIPI.

J Antimicrob Chemother. 2014 Oct;69(10):2629-33. doi: 10.1093/jac/dku179. Epub 2014 May 30.

PMID:
24879663
8.

Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013.

Guevara M, Ezpeleta C, Gil-Setas A, Torroba L, Beristain X, Aguinaga A, García-Irure JJ, Navascués A, García-Cenoz M, Castilla J; Working Group for Surveillance of the Pneumococcal Disease in Navarre.

Vaccine. 2014 May 7;32(22):2553-62. doi: 10.1016/j.vaccine.2014.03.054. Epub 2014 Mar 25.

PMID:
24674661
9.

Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.

Castilla J, Martínez-Baz I, Navascués A, Fernandez-Alonso M, Reina G, Guevara M, Chamorro J, Ortega MT, Albéniz E, Pozo F, Ezpeleta C; Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre.

Euro Surveill. 2014 Feb 13;19(6). pii: 20700.

10.

Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.

Peralta G, Lamelo M, Alvarez-García P, Velasco M, Delgado A, Horcajada JP, Montero M, Roiz MP, Fariñas MC, Alonso J, Martínez LM, Gutiérrez-Macías A, Alava JA, Rodríguez A, Fleites A, Navarro V, Sirvent E, Capdevila JA; SEMI- BLEE STUDY GROUP.

BMC Infect Dis. 2012 Oct 5;12:245. doi: 10.1186/1471-2334-12-245.

11.

Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance.

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López-Fabal F, Gómez M; VIRA Study Group.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):373-9. doi: 10.1016/j.diagmicrobio.2011.02.009.

PMID:
21683269
12.

Clinical features of infections and colonization by Acinetobacter genospecies 3.

Molina J, Cisneros JM, Fernández-Cuenca F, Rodríguez-Baño J, Ribera A, Beceiro A, Martínez-Martínez L, Pascual Á, Bou G, Vila J, Pachón J; Spanish Group for Nosocomial Infection (GEIH).

J Clin Microbiol. 2010 Dec;48(12):4623-6. doi: 10.1128/JCM.01216-10. Epub 2010 Oct 13.

13.

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.

Guevara M, Barricarte A, Gil-Setas A, García-Irure JJ, Beristain X, Torroba L, Petit A, Polo Vigas ME, Aguinaga A, Castilla J.

Clin Microbiol Infect. 2009 Nov;15(11):1013-9. doi: 10.1111/j.1469-0691.2009.02904.x. Epub 2009 Aug 7.

14.

B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain.

Castilla J, Vázquez JA, Salcedo C, García Cenoz M, García Irure JJ, Torroba L, Beristain X, Abad R, Barricarte A.

J Clin Microbiol. 2009 Feb;47(2):463-5. doi: 10.1128/JCM.01495-08. Epub 2008 Dec 17.

15.

Detection and reporting beta-lactam resistance phenotypes in Escherichia coli and Klebsiella pneumoniae: a multicenter proficiency study in Spain.

Conejo MC, Mata C, Navarro F, Pascual A; GEMARA collaborative group.

Diagn Microbiol Infect Dis. 2008 Nov;62(3):317-25. doi: 10.1016/j.diagmicrobio.2008.06.010. Epub 2008 Aug 8.

PMID:
18692340
16.

[Bacteriemia and hepatic abscess secondary to Yersinia pseudotuberculosis infection].

Navascués A, Etxeberría D, García-Irure JJ, Dorronsoro I.

Enferm Infecc Microbiol Clin. 2005 Jan;23(1):47-8. Spanish. No abstract available.

PMID:
15701336
17.

[Bacteremia and hepatic abscess caused by Yersinia enterocolitica].

Navascués A, Gasteasi C, Salicio Y, García-Irure JJ.

An Sist Sanit Navar. 2004 May-Aug;27(2):249-51. Spanish.

PMID:
15381958
18.

[Antibiotic sensitivity and treatment recommendations for Streptococcus pneumoniae].

Gil-Setas A, Mazón A, Torroba L, Barricarte A, García-Irure JJ, Petit A, Polo ME.

An Sist Sanit Navar. 2004 Jan-Apr;27(1):37-43. Spanish.

19.

[State of methicillin resistant Staphylococcus aureus in the Hospital of Navarre (2000-2002)].

Navascués A, García Irure JJ, Guillén F.

An Sist Sanit Navar. 2004 Jan-Apr;27(1):21-5. Spanish.

20.

[Spontaneous bacterial peritonitis and bacteraemia due to Aeromonas hydrophila].

García-Irure JJ, Navascués A, Vivanco M, Rodrígo A.

An Sist Sanit Navar. 2003 Sep-Dec;26(3):429-31. Spanish.

Supplemental Content

Loading ...
Support Center